Workflow
核技术应用
icon
Search documents
陈泽民第三次创业,投资前沿产业“核电池”
Sou Hu Cai Jing· 2025-09-27 10:36
Core Insights - The collaboration between Chen Zemin, founder of Sanquan Foods, and Dr. Li Gang, founder of Wuxi Beta, marks a significant venture into the carbon-14 full industry chain and nuclear battery fields, which Chen views as his "third start" in entrepreneurship [1][3] Company Developments - Chen Zemin's entrepreneurial journey reflects a response to the evolving market, transitioning from food production with Sanquan Foods to geothermal energy, and now to nuclear technology applications [3] - Wuxi Beta has been dedicated to the research and development of carbon-14 nuclear materials and nuclear batteries since 2008, overcoming numerous challenges in this "unmanned zone" of technology [3][4] Industry Potential - Chen Zemin recognizes the vast potential of nuclear battery technology, highlighting its low energy consumption and long lifespan, with applications in medical devices, aerospace, deep-sea monitoring, and nuclear waste recycling [3][4] - The partnership aims to accelerate technological iteration and product mass production, with aspirations to establish Wuxi and Zhengzhou as innovation hubs for nuclear battery applications, promoting the development of the industry chain [4]
受权发布|中华人民共和国原子能法
Xin Hua She· 2025-09-12 15:31
Core Points - The law aims to ensure the research, development, and peaceful use of atomic energy, promote technological advancement and industrial upgrading, and enhance national security and public welfare [3][4][5] Group 1: General Principles - The law applies to atomic energy research, development, and utilization activities within the territory of the People's Republic of China and other sea areas under its jurisdiction [3] - Activities related to atomic energy must adhere to the leadership of the Communist Party of China and follow a comprehensive national security perspective [4] - The development of atomic energy technology and industry should focus on innovation-driven strategies and sustainable development [5] Group 2: Management and Supervision - The State Council's nuclear industry and energy departments are responsible for managing and supervising atomic energy activities [6] - Local governments are required to support atomic energy activities and fulfill their management and supervision responsibilities according to laws and regulations [6] Group 3: Scientific Research and Technology Development - The state will strengthen scientific research and technology development in the atomic energy field, encouraging independent research and enhancing intellectual property protection [10][11] - The establishment of innovation bases and platforms in the atomic energy sector is encouraged to promote the sharing of research facilities and resources [10] Group 4: Nuclear Fuel Cycle - A complete nuclear fuel cycle system will be established, including exploration, mining, refining, and waste management [13][14] - The State Council's nuclear industry department will organize the development of long-term plans for the nuclear fuel cycle [13] Group 5: Utilization - The state will actively promote the safe and orderly development of nuclear power and encourage the application of advanced nuclear reactors [17][18] - Nuclear reactors will be utilized for various applications, including power generation, heating, desalination, and hydrogen production [18] Group 6: Safety Supervision and Management - Safety is a primary concern in atomic energy activities, with strict adherence to safety regulations and responsibilities [21] - The establishment of a nuclear security system is mandated to protect against theft, sabotage, and nuclear terrorism [22] Group 7: Import and Export - The state will strengthen the management of imports and exports in the atomic energy sector, ensuring compliance with international obligations [27][28] - Strict controls will be placed on the export of sensitive nuclear materials and technologies [28] Group 8: Legal Responsibilities - Violations of the law will result in penalties, including fines and disciplinary actions against responsible personnel [30][31] - A compensation system for nuclear damage will be established to address damages caused by nuclear accidents [32]
中国核技术应用觉醒:一场被低估的产业革命正在发生
Zheng Quan Zhi Xing· 2025-09-04 07:53
Core Insights - The article highlights the rapid development of non-power nuclear technology applications in various sectors, with China's market value exceeding 700 billion yuan in 2022, yet only accounting for 0.57% of GDP, indicating significant growth potential compared to developed countries' 2%-3% [1] - A three-year action plan was jointly released by twelve government departments in China, aiming for a direct output value of 400 billion yuan by 2026, emphasizing the need for self-sufficiency in isotope supply and the creation of industrial clusters [1][2] - Stable isotopes are identified as the "invisible cornerstone" of nuclear technology applications, playing a crucial role in medical diagnostics, industrial testing, and agricultural research [1][3] Industry Overview - Stable isotopes, which do not decay and are non-radioactive, are essential for high-precision tracking and analysis in various fields, including medicine and industry [2] - Current production methods for stable isotopes involve high technical barriers and significant equipment investment, with China still relying heavily on imports for high-purity stable isotopes [2][3] - The Chinese market is witnessing a shift towards domestic production of stable isotopes, driven by policy support and increasing market demand [2][3] Market Dynamics - The demand for stable isotopes is surging in nuclear medicine, agriculture, and environmental monitoring, with specific isotopes like Fluorine-18 and Carbon-13 being pivotal in various applications [3][4] - Companies like China Nuclear Group and China General Nuclear Power Corporation are making strides in domestic production capabilities, with significant breakthroughs in medical isotopes [4][5] - The stable isotope industry is characterized by high technical intensity and substantial initial investment, with a growing recognition of its value in enhancing the competitiveness of high-end industries [3][6] Competitive Landscape - The nuclear medicine sector is becoming increasingly competitive, with companies like East China Pharmaceutical and China Nuclear Group emerging as key players, capturing significant market shares [5][6] - The collaboration between companies and research institutions is fostering innovation and expanding the application of stable isotopes in various fields, including cancer treatment and environmental monitoring [5][6] - The formation of a billion-level industry chain is underway, with implications for both patient care and China's positioning in the global nuclear technology application landscape [6]
中国同辐:放射源研发生产基地成功获批辐射安全许可证
Zhi Tong Cai Jing· 2025-08-22 12:08
Core Viewpoint - China Tongyuan (01763) announced that its subsidiary, Sichuan Nuclear Tongyuan Technology Co., Ltd., has successfully obtained a radiation safety license for its radiation source R&D and production base, marking its official qualification for production and sales of radiation sources [1] Group 1: Project Overview - The project is the largest radiation source R&D and production base in Asia, featuring 13 production lines for various radiation sources, including Carbon-14 and Krypton-85 [1] - Upon completion, the annual production capacity will exceed 100,000 radiation sources [1] Group 2: Product and Service Offerings - China Tongyuan will consolidate domestic resources for R&D and production of radiation sources, offering over 70 types of high-quality radiation source products to both domestic and international markets [1] - The company will provide radiation source resource recycling services and irradiation services, contributing positively to applications in industries such as agriculture, medicine, national defense, and aerospace [1] Group 3: Future Plans - The company plans to promote the second phase of the project with high standards to further expand production capacity and diversify its product offerings [1] - Future production lines will include sources such as Californium-252, Cesium-137, and Americium-241 to meet diverse market demands [1]
中国同辐(01763) - 自愿性公告 - 中国同辐放射源研发生產基地成功获批辐射安全许可证
2025-08-22 11:52
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 自願性公告 CHINA ISOTOPE & RADIATION CORPORATION 中國同輻股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:1763) 中國同輻放射源研發生產基地成功獲批輻射安全許可證 本公告乃中國同輻股份有限公司(「中國同輻」或「本公司」)自願發出以使股東及潛 在投資者知悉本公司之最新業務進展。 本公司董事會欣然宣佈,近日,中國同輻旗下附屬公司四川中核同源科技有限公 司的放射源研發生產基地「該項目」成功獲批輻射安全許可證,正式具備放射源生 產、銷售等相關資質,產品將逐步面向市場。 該項目是亞洲最大的放射源研發生產基地,建設包括碳-14源、氪-85源等13條放 射源生產線,該項目建成後年產放射源將超過10萬枚。中國同輻將聚集國內主要 放射源的研發、生產資源,向國內外提供超過70種核素的高質量放射源產品,可 提供放射源資源再利用服務、輻照服務等,為我國工業、農業、 ...
打破垄断!重大突破!
证券时报· 2025-06-25 07:56
Core Viewpoint - The domestic high-performance silicon photomultiplier (SiPM) has achieved significant breakthroughs in localization, marking a successful end to foreign monopolies in this field [1][2]. Group 1: Company Achievements - China General Nuclear Power Corporation's subsidiary, CGN Technology Development Co., Ltd., has successfully established a SiPM packaging production line with a device yield exceeding 90% [2]. - The successful production line fills the gap in domestic high-performance SiPM products, providing strong support for the stability of the industrial chain [4]. - The production line has passed EU RoHS certification and is on track to obtain ISO certification, laying a solid foundation for large-scale application and market expansion [4]. Group 2: Market Potential and Applications - SiPMs are widely used in advanced fields such as nuclear medical imaging, nuclear measurement and control equipment, high-energy physics research, and biological sciences due to their high sensitivity, low noise, and low power consumption [4]. - The domestic SiPM market has long been dominated by foreign companies, and achieving self-control of core components has been included in national development plans [4]. Group 3: Future Plans and Strategies - The company aims to continuously optimize and enhance SiPM product performance based on market demand and customer feedback, focusing on building core competitiveness [6]. - CGN Technology Development Co., Ltd. is committed to becoming a leader in the non-power nuclear technology application industry and is exploring new models for mixed-ownership development [7].
中广核技:2024年净亏损3.62亿元
news flash· 2025-04-28 11:09
Core Viewpoint - China General Nuclear Power Technology Co., Ltd. (中广核技) reported a revenue of 6.168 billion yuan for 2024, reflecting a year-on-year decline of 2.90% [1] - The company recorded a net loss attributable to shareholders of 362 million yuan, an improvement from a net loss of 737 million yuan in the same period last year [1] - The company announced plans not to distribute cash dividends, issue bonus shares, or increase capital through reserves [1] Financial Performance - Revenue for 2024 was 6.168 billion yuan, down 2.90% compared to the previous year [1] - Net loss for the period was 362 million yuan, compared to a net loss of 737 million yuan in the same quarter last year, indicating a reduction in losses [1] Dividend Policy - The company will not distribute cash dividends for the current fiscal year [1] - There will be no issuance of bonus shares or capital increase from reserves [1]
原子能法草案二次审议稿提请审议
Ke Ji Ri Bao· 2025-04-28 01:04
Group 1 - The draft of the Atomic Energy Law has been submitted for a second review, focusing on improving the management system for spent fuel [1] - The draft emphasizes the establishment of a comprehensive management system for the storage, transportation, and disposal of spent fuel, ensuring its safe, efficient, and environmentally friendly handling [1] - The draft encourages and supports scientific research and technological development in controlled nuclear fusion, establishing a supervisory management system tailored to fusion characteristics [1] Group 2 - The application of nuclear technology in various fields such as industry, agriculture, biology, medicine, and ecological environment protection is highlighted, with the state supporting the use of radioactive isotopes and radiation devices [1] - The draft includes provisions for classified management of radioactive isotopes and radiation devices, with specific classification methods to be determined by relevant government departments [1] - The atomic energy industry is recognized as a high-tech strategic industry and a cornerstone of national security, with requirements for confidentiality management in related research and development activities [1] Group 3 - The draft enhances emergency management for nuclear accidents by requiring the formulation of national emergency response plans and conducting emergency drills by relevant departments and nuclear facility operators [1] - The initial review of the Atomic Energy Law draft took place in April 2024, emphasizing the need for a comprehensive legal framework in the nuclear sector to modernize governance capabilities [2]